ACCC's Innovative Quality Improvement Workshop
The Association of Cancer Care Centers (ACCC) is excited to present a transformative opportunity aimed at advancing the integration of biomarker testing into treatment protocols for patients diagnosed with gynecologic cancers. This quality improvement (QI) workshop is crafted to empower cancer centers to improve accessibility to vital testing, bridging the gaps currently faced in this essential aspect of care.
Understanding the Importance of Biomarker Testing
Biomarker testing serves as a pivotal component in both diagnosing and tailoring treatments for patients suffering from gynecologic cancers. Despite its critical role, numerous obstacles hinder patients from accessing necessary testing. Financial constraints, insufficient care coordination, and a lack of awareness among healthcare providers are just a few of the significant barriers that many face.
Workshop Objectives for Cancer Centers
This well-structured initiative encourages cancer centers to take proactive steps towards enhancing biomarker testing access. By participating in this QI initiative, cancer centers will focus on:
Identifying Gaps in Testing
One key objective involves identifying current gaps in implementing guideline-concordant biomarker testing. Understanding barriers in testing, including those for HRD, MMR/MSI, and HER2, will be a priority for participating centers.
Tackling Social Determinants of Health
Another vital focus is addressing the social drivers of health (SDOH) that contribute to healthcare disparities. Issues such as financial toxicity, coordination of genetic testing, and necessary education for healthcare providers will be pivotal themes in discussions and strategies developed during the workshop.
Elevating Patient Care
Furthermore, participants will work towards developing actionable strategies and gaining access to valuable resources to effectively integrate biomarker testing into standard care practices. Selected centers will receive a stipend of $10,000 to support their engagement in this crucial program.
Participate in the Change
Centers interested in this workshop and QI initiative are encouraged to connect with Bianca Alvarez, MPH, CHES, to explore participation options. This initiative not only emphasizes the importance of biomarker testing but also reinforces ACCC’s dedication to fostering equitable, patient-centric care that addresses the unique hurdles presented in gynecologic cancer treatment.
About the Association of Cancer Care Centers
The Association of Cancer Care Centers (ACCC) stands as a premier education and advocacy organization dedicated to the cancer care community. With a vibrant network that includes over 45,000 multidisciplinary professionals, ACCC focuses on improving access, quality, and equitable delivery of cancer care services. They play a fundamental role in equipping healthcare providers with the necessary tools and knowledge to provide superior cancer care.
Frequently Asked Questions
What is the purpose of the ACCC workshop?
The ACCC workshop aims to enhance access to biomarker testing for patients with gynecologic cancers by identifying gaps and promoting actionable strategies.
Who can participate in this QI initiative?
Cancer centers interested in improving healthcare quality and access for gynecologic cancer patients are encouraged to participate.
What support do participating centers receive?
Participating centers will receive a stipend of $10,000 and access to valuable resources to facilitate their involvement.
Why is biomarker testing essential?
Biomarker testing is crucial for accurately diagnosing and treating gynecologic cancers, ensuring patients receive tailored care for better outcomes.
How can I contact ACCC for more information?
Interested parties should reach out to Bianca Alvarez, MPH, CHES, to learn more about participation opportunities in the workshop.
